![]() |
|||
|
|
|
|
| UPDATE: May 2009 | MW: 372.55 | MF: C23H32O4 |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
parenteral | rat
lowest published toxic dose: 316 mg/kg (56 day prior to copulation/1-22 day pregnant)
|
Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
|
PSEBAA 120,238,1965
|
parenteral | rat
lowest published toxic dose: 224 mg/kg (56 day prior to copulation)
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated)
|
PSEBAA 120,238,1965
|
subcutaneous | rat
lowest published toxic dose: 1,258 mg/kg (20 day male)
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
ENDOAO 28,129,1941
|
unreported route | rat
lowest published toxic dose: 16 mg/kg (2 day male)
|
Reproductive: Effects on fertility: Mating performance (e.g., # sperm positive females per # females mated; # copulations per # estrus cycles)
|
ANENAG 24(Suppl 3),1,1963
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
subcutaneous | mouse
lowest published toxic dose: 520 mg/kg/13 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Tumorigenic: Tumors at site of application
PSEBAA 83,14,1953
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
subcutaneous | rat
lowest published toxic dose: 200 mg/kg
|
Vascular: BP elevation not characterized in autonomic section
|
JPETAB 321,485,2007
|
subcutaneous | rat
lowest published toxic dose: 200 mg/kg
|
Reproductive: Other effects on male
|
TOXIA6 51,1197,2008
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | monkey
lowest published toxic dose: 3.5 mg/kg/8 week- intermittent
|
Vascular: BP elevation not characterized in autonomic section | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Nutritional and Gross Metabolic: Changes in: K
PBBHAU 38,55,1991
|
parenteral | rabbit
lowest published toxic dose: 35 mg/kg/7 day- intermittent
|
Liver: Other changes
|
ANREAK 113,349,1952
|
subcutaneous | mouse
lowest published toxic dose: 450 mg/kg/2 week- intermittent
|
Vascular: BP elevation not characterized in autonomic section
|
EJPHAZ 552,131,2006
|
subcutaneous | mouse
lowest published toxic dose: 1,125 mg/kg/5 week- intermittent
|
Vascular: Structural changes in vessels
|
EJPHAZ 552,131,2006
|
subcutaneous | rat
lowest published toxic dose: 180 mg/kg/3 week- intermittent
|
Cardiac: Changes in heart weight | Vascular: BP elevation not characterized in autonomic section
CEXPB9 27,277,2000
|
subcutaneous | rat
lowest published toxic dose: 175 mg/kg/2 week- intermittent
|
Vascular: BP elevation not characterized in autonomic section
|
CEXPB9 27,818,2000
|
subcutaneous | rat
lowest published toxic dose: 700 mg/kg/8 week- intermittent
|
Vascular: BP elevation not characterized in autonomic section | Kidney, Ureter, and Bladder: Changes in both tubules and glomeruli Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
CEXPB9 27,818,2000
|
subcutaneous | rat
lowest published toxic dose: 1,400 mg/kg/8 week- intermittent
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)
|
CEXPB9 27,818,2000
|
subcutaneous | rat
lowest published toxic dose: 30 mg/kg/1 week- intermittent
|
Vascular: BP elevation not characterized in autonomic section
|
BIPBU* 24,1181,2001
|
subcutaneous | rat
lowest published toxic dose: 150 mg/kg/5 week- intermittent
|
Cardiac: Changes in heart weight | Vascular: BP elevation not characterized in autonomic section Nutritional and Gross Metabolic: Weight loss or decreased weight gain
BIPBU* 24,1181,2001
|
subcutaneous | rat
lowest published toxic dose: 100 mg/kg/4 week- intermittent
|
Vascular: BP elevation not characterized in autonomic section
|
FCLPH* 17,323,2003
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
CNREA8 17,432,1957
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X5546 |
Number of Industries 1; Total Number of Facilities 17; Number of Occupations 2; Total Number of Employees Exposed 968; Total Number of Female Employees Exposed 494 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
N/R
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
ANENAG
|
Annales d'Endocrinologie. (Masson Editeur, 120 Blvd. Saint-Germain, F-25280 Paris Cedex 06,
France) V.1- 1939-
|
ANREAK
|
Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08-
|
BIPBU*
|
Biological & pharmaceutical bulletin. (Pharmaceutical Society of Japan, 2-12-15, Shibuya,
Shibuya-ku, Tokyo 150-0002, Japan) V.1- 1993-
|
CEXPB9
|
Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications,
(Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974-
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
EJPHAZ
|
European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1967-
|
ENDOAO
|
Endocrinology (Baltimore). (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21203)
V.1- 1917-
|
FCLPH*
|
Fundamental & Clinical Pharmacology (Oxford : Blackwell Science) 2001-
|
JPETAB
|
Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E.
Preston St., Baltimore, MD 21202) V.1- 1909/10-
|
PBBHAU
|
Pharmacology, Biochemistry and Behavior. (ANKHO International Inc., P.O. Box 426,
Fayetteville, NY 13066) V.1- 1973-
|
PSEBAA
|
Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1903/04-
|
TOXIA6
|
Toxicon. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, UK) V.1- 1962-
|
| |